\-\ Texto\\:\\ \ \(0\)\
\-\ large\\ palpable\\ mass\\ in\\ the\\ posterolateral\\ popliteal\\ fossa\\ of\\ the\\ left\\ knee\\.\\ no\\ laboratory\\ data\\ available\\.\ \(0\)\
\-\ actual\\ treatment\\/follow\\-up\\ documentation\\ not\\ available\\.\\ see\\ likely\\ treatment\\ course\\ in\\ discussion\\ below\\.\ \(0\)\
\-\ large\\,\\ lobulated\\,\\ cloud\\-like\\,\\ calcified\\ mass\\ with\\ fairly\\ well\\ defined\\ margins\\ on\\ posterolateral\\ aspect\\ of\\ the\\ left\\ popliteal\\ fossa\\.\ \(0\)\
\-\ tumoral\\ calcinosis\ \(1\)\
\-\ tumoral\\ calcinosisheterotopic\\ ossificationparosteal\\ osteosarcoma\ \(0\)\
\-\ 59\\ y\\/o\\ female\\ presents\\ with\\ a\\ large\\ palpable\\ mass\\ in\\ the\\ posterolateral\\ popliteal\\ fossa\\ of\\ her\\ left\\ knee\ \(1\)\
\-\ tumoral\\ calcinosis\\ is\\ a\\ rare\\ genetic\\ disorder\\ that\\ typically\\ presents\\ in\\ young\\ african\\ men\\.\\ it\\ is\\ characterized\\ by\\ an\\ increase\\ in\\ proximal\\ tubular\\ phosphate\\ transport\\,\\ often\\ in\\ association\\ with\\ increased\\ serum\\ 1\\,25\\(oh\\)2\\ d3\\ concentrations\\.\\ serum\\ calcium\\ and\\ pth\\ concentrations\\ are\\ typically\\ within\\ the\\ normal\\ range\\.\\ the\\ combination\\ of\\ hyperphosphatemia\\ and\\ normocalcemia\\ results\\ in\\ a\\ high\\ calcium\\-phosphate\\ product\\ and\\ calcium\\-phosphate\\ deposition\\ in\\ soft\\ tissues\\.\\ these\\ depositions\\ present\\ as\\ swellings\\,\\ sometimes\\ painful\\,\\ around\\ large\\ joints\\.\\ they\\ arise\\ in\\ the\\ fascial\\ planes\\ between\\ muscles\\,\\ and\\ calcify\\ or\\ ossify\\,\\ usually\\ appearing\\ well\\ circumscribed\\,\\ lobulated\\ and\\ solid\\.treatment\\ is\\ based\\ on\\ phosphate\\ depletion\\ with\\ diet\\ and\\ antacids\\.\\ the\\ chronic\\ administration\\ of\\ acetazolamide\\ may\\ also\\ aid\\ in\\ the\\ resolution\\ of\\ the\\ deposits\\ by\\ increasing\\ urinary\\ phosphate\\ excretion\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ phosphate\\:\\ 0\\.42508859792487846\ \(0\)\
\-\ tumoral\\:\\ 0\\.24968991989909953\ \(0\)\
\-\ popliteal\\:\\ 0\\.21404517694726607\ \(0\)\
\-\ posterolateral\\:\\ 0\\.2027230208301249\ \(0\)\
\-\ calcium\\:\\ 0\\.17925725654305946\ \(0\)\
\-\ calcinosis\\:\\ 0\\.17426434930189963\ \(0\)\
\-\ concentrations\\:\\ 0\\.17426434930189963\ \(0\)\
\-\ in\\:\\ 0\\.1645740591511645\ \(0\)\
\-\ fossa\\:\\ 0\\.1558038804292624\ \(0\)\
\-\ large\\:\\ 0\\.13258927771002108\ \(0\)\
\-\ the\\:\\ 0\\.13200471134764527\ \(0\)\
\-\ lobulated\\:\\ 0\\.12204610992026504\ \(0\)\
\-\ serum\\:\\ 0\\.1186456731957724\ \(0\)\
\-\ calcinosisheterotopic\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ ossificationparosteal\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ hyperphosphatemia\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ normocalcemia\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ depositions\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ swellings\\:\\ 0\\.10579746145059576\ \(0\)\
\-\ d3\\:\\ 0\\.09775875997627151\ \(0\)\
\-\ antacids\\:\\ 0\\.09775875997627151\ \(0\)\
\-\ acetazolamide\\:\\ 0\\.09775875997627151\ \(0\)\
\-\ ossify\\:\\ 0\\.09517087612527408\ \(0\)\
\-\ knee\\:\\ 0\\.09483929782087178\ \(0\)\
\-\ treatment\\:\\ 0\\.09454049563446777\ \(0\)\
\-\ oh\\:\\ 0\\.09305642105929995\ \(0\)\
\-\ depletion\\:\\ 0\\.09305642105929995\ \(0\)\
\-\ palpable\\:\\ 0\\.09295368338324692\ \(0\)\
\-\ typically\\:\\ 0\\.09288413373742047\ \(0\)\
\-\ available\\:\\ 0\\.08976954631815527\ \(0\)\
\-\ fascial\\:\\ 0\\.08835408214232839\ \(0\)\
\-\ documentation\\:\\ 0\\.08713217465094981\ \(0\)\
\-\ transport\\:\\ 0\\.08602682487185644\ \(0\)\
\-\ actual\\:\\ 0\\.08242983573397825\ \(0\)\
\-\ and\\:\\ 0\\.08202166644301992\ \(0\)\
\-\ calcify\\:\\ 0\\.07968834175977849\ \(0\)\
\-\ product\\:\\ 0\\.07909347317662554\ \(0\)\
\-\ pth\\:\\ 0\\.07852763438272828\ \(0\)\
\-\ of\\:\\ 0\\.07767833578564477\ \(0\)\
\-\ mass\\:\\ 0\\.07580920215704322\ \(0\)\
\-\ deposits\\:\\ 0\\.07519127182537558\ \(0\)\
\-\ excretion\\:\\ 0\\.07519127182537558\ \(0\)\
\-\ aid\\:\\ 0\\.07293956788239105\ \(0\)\
\-\ diet\\:\\ 0\\.0719589224742151\ \(0\)\
\-\ fairly\\:\\ 0\\.06943389728524313\ \(0\)\
\-\ planes\\:\\ 0\\.06823722896541948\ \(0\)\
\-\ left\\:\\ 0\\.0677015171784386\ \(0\)\
\-\ men\\:\\ 0\\.06736153807221047\ \(0\)\
\-\ deposition\\:\\ 0\\.06674560246282452\ \(0\)\
\-\ genetic\\:\\ 0\\.06524708300623634\ \(0\)\
\-\ data\\:\\ 0\\.06490086640806678\ \(0\)\
\-\ well\\:\\ 0\\.06406588965642139\ \(0\)\
\-\ presents\\:\\ 0\\.06364867020211087\ \(0\)\
\-\ 59\\:\\ 0\\.06272970025230348\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.0625891240492762\ \(0\)\
\-\ sometimes\\:\\ 0\\.06191072044888364\ \(0\)\
\-\ combination\\:\\ 0\\.061395195810918866\ \(0\)\
\-\ characterized\\:\\ 0\\.06078143383001875\ \(0\)\
\-\ arise\\:\\ 0\\.060544744089264774\ \(0\)\
\-\ african\\:\\ 0\\.059752418847686485\ \(0\)\
\-\ association\\:\\ 0\\.059535638802384036\ \(0\)\
\-\ painful\\:\\ 0\\.058508650096767374\ \(0\)\
\-\ discussion\\:\\ 0\\.05793345479187272\ \(0\)\
\-\ tubular\\:\\ 0\\.057475000049926686\ \(0\)\
\-\ urinary\\:\\ 0\\.05720838153191207\ \(0\)\
\-\ joints\\:\\ 0\\.056862164933742514\ \(0\)\
\-\ muscles\\:\\ 0\\.0566928568939473\ \(0\)\
\-\ margins\\:\\ 0\\.05644344094237808\ \(0\)\
\-\ by\\:\\ 0\\.056187144616226585\ \(0\)\
\-\ disorder\\:\\ 0\\.05596014623183234\ \(0\)\
\-\ young\\:\\ 0\\.05455042257495195\ \(0\)\
\-\ below\\:\\ 0\\.054480768343034496\ \(0\)\
\-\ is\\:\\ 0\\.054351612533045525\ \(0\)\
\-\ resolution\\:\\ 0\\.05367600200265468\ \(0\)\
\-\ calcified\\:\\ 0\\.05329363567456914\ \(0\)\
\-\ increase\\:\\ 0\\.05310707838502539\ \(0\)\
\-\ appearing\\:\\ 0\\.052862913687678634\ \(0\)\
\-\ around\\:\\ 0\\.052802667345689495\ \(0\)\
\-\ administration\\:\\ 0\\.052683105516109385\ \(0\)\
\-\ tissues\\:\\ 0\\.052159826016770945\ \(0\)\
\-\ increasing\\:\\ 0\\.05210311492698178\ \(0\)\
\-\ with\\:\\ 0\\.051816499048511315\ \(0\)\
\-\ results\\:\\ 0\\.05155075364157654\ \(0\)\
\-\ range\\:\\ 0\\.051336970726346895\ \(0\)\
\-\ circumscribed\\:\\ 0\\.05123153913884644\ \(0\)\
\-\ rare\\:\\ 0\\.04994161154190964\ \(0\)\
\-\ course\\:\\ 0\\.048866179510480244\ \(0\)\
\-\ laboratory\\:\\ 0\\.04804039343872292\ \(0\)\
\-\ based\\:\\ 0\\.04792144475750808\ \(0\)\
\-\ they\\:\\ 0\\.047269518726529916\ \(0\)\
\-\ defined\\:\\ 0\\.04719517619790688\ \(0\)\
\-\ often\\:\\ 0\\.043166628851668075\ \(0\)\
\-\ between\\:\\ 0\\.04298480706871219\ \(0\)\
\-\ aspect\\:\\ 0\\.042679594855340404\ \(0\)\
\-\ usually\\:\\ 0\\.04164750166251449\ \(0\)\
\-\ her\\:\\ 0\\.0413303656390681\ \(0\)\
\-\ proximal\\:\\ 0\\.0413303656390681\ \(0\)\
\-\ see\\:\\ 0\\.0411529641723165\ \(0\)\
\-\ on\\:\\ 0\\.03996034977571047\ \(0\)\
\-\ likely\\:\\ 0\\.03953304659654037\ \(0\)\
\-\ chronic\\:\\ 0\\.03926816799222676\ \(0\)\
\-\ high\\:\\ 0\\.037598599054006164\ \(0\)\
\-\ these\\:\\ 0\\.037358146873017764\ \(0\)\
\-\ increased\\:\\ 0\\.03577388892946354\ \(0\)\
\-\ soft\\:\\ 0\\.03521991852625124\ \(0\)\
\-\ present\\:\\ 0\\.033946668832245744\ \(0\)\
\-\ it\\:\\ 0\\.033864208593261114\ \(0\)\
\-\ may\\:\\ 0\\.033291664164743835\ \(0\)\
\-\ female\\:\\ 0\\.031923205220345675\ \(0\)\
\-\ also\\:\\ 0\\.03111777324925836\ \(0\)\
\-\ within\\:\\ 0\\.030469302778062802\ \(0\)\
\-\ that\\:\\ 0\\.02870911864085202\ \(0\)\
\-\ normal\\:\\ 0\\.027010952975401913\ \(0\)\
\-\ as\\:\\ 0\\.02657711644881016\ \(0\)\
\-\ not\\:\\ 0\\.026116720135381615\ \(0\)\
\-\ an\\:\\ 0\\.025297740331961777\ \(0\)\
\-\ are\\:\\ 0\\.025103101950816765\ \(0\)\
\-\ or\\:\\ 0\\.023014410704789424\ \(0\)\
\-\ no\\:\\ 0\\.02151310019246189\ \(0\)\
